Indian drug firm secures drug patents in three countries

Suven Life Sciences has ten internally-discovered therapeutic drug candidates currently in pre-clinical stage of development for ADHD, dementia, depression, Huntington’s disease and Parkinson’s disease The Dollar Business Bureau

With these new patents, the company has so far secured 21 granted patents from Canada, 19 from South Korea and two from ARIPO

Hyderabad-based Suven Life Sciences Ltd. on Tuesday announced that it has secured one patent each in Canada, ARIPO (African Regional Intellectual Property Organisation) and South Korea for the treatment of disorders associated with neurodegenerative diseases. These patents are being developed as therapeutic agents and will be valid through 2030. “The granted claims of the patents include the class of selective 5-HT compounds and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia,” Suven Life Sciences Ltd. said in a statement. With these three new patents, the company has so far secured 21 granted patents from Canada, 19 from South Korea and two from ARIPO. “We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,” said Venkat Jasti, CEO, Suven Life Sciences Ltd. Currently, the company has 3 clinical stage compounds, a Phase 2 undergoing candidate SUVN-502, Phase 1 completed candidate SUVN-G3031 and Phase 1 undergoing candidate SUVN-D4010 for Alzheimer’s disease and Schizophrenia. The Indian drug major also has ten internally-discovered therapeutic drug candidates currently in their pre-clinical stage of development for ADHD, dementia, depression, Huntington’s disease and Parkinson’s disease.

December 05, 2015 | 4:28pm IST.

Related Topics:

The Dollar Business Bureau - Jan 05, 2016 10:57 IST

Indian drug firm secures drug patents in three countries

We like you just the way you are.